Search by Drug Name or NDC

    NDC 25021-0410-70 Enoxaparin Sodium 100 mg/mL Details

    Enoxaparin Sodium 100 mg/mL

    Enoxaparin Sodium is a SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is ENOXAPARIN SODIUM.

    Product Information

    NDC 25021-0410
    Product ID 25021-410_0f60383f-d466-4b5b-a501-62dda52eb3b7
    Associated GPIs
    GCN Sequence Number 019331
    GCN Sequence Number Description enoxaparin sodium SYRINGE 30MG/0.3ML SUBCUT
    HIC3 M9K
    HIC3 Description HEPARIN AND RELATED PREPARATIONS
    GCN 00420
    HICL Sequence Number 007878
    HICL Sequence Number Description ENOXAPARIN SODIUM
    Brand/Generic Generic
    Proprietary Name Enoxaparin Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Enoxaparin Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units mg/mL
    Substance Name ENOXAPARIN SODIUM
    Labeler Name Sagent Pharmaceuticals
    Pharmaceutical Class Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078990
    Listing Certified Through 2024-12-31

    Package

    NDC 25021-0410-70 (25021041070)

    NDC Package Code 25021-410-70
    Billing NDC 25021041070
    Package 10 SYRINGE in 1 CARTON (25021-410-70) / .3 mL in 1 SYRINGE
    Marketing Start Date 2023-10-01
    NDC Exclude Flag N
    Pricing Information N/A